Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 2,159 | 2,034 | 1,316 | 901 | 758 |
| Cost of Goods | 1,687 | 1,626 | 1,785 | 1,294 | 1,501 |
| Gross Profit | 472 | 408 | -469 | -393 | -743 |
| Operating Expenses | 6,641 | 6,428 | 6,421 | 5,616 | 6,407 |
| Operating Income | -5,482 | -5,394 | -6,105 | -5,715 | -6,649 |
| Other Income | -44 | -11 | -209 | 147 | 18 |
| Pre-tax Income | -5,526 | -5,405 | -6,314 | -5,568 | -6,631 |
| Income Tax | 32 | 30 | -1 | 12 | 11 |
| Net Income Continuous | -5,558 | -5,435 | -6,313 | -5,580 | -6,642 |
| Net Income | $-5,558 | $-5,435 | $-6,313 | $-5,580 | $-6,642 |
| EPS Basic Total Ops | -0.28 | -0.19 | -0.31 | -0.39 | -0.56 |
| EPS Basic Continuous Ops | -0.28 | -0.18 | -0.32 | -0.39 | -0.56 |
| EPS Diluted Total Ops | -0.28 | -0.19 | -0.31 | -0.39 | -0.56 |
| EPS Diluted Continuous Ops | -0.28 | -0.18 | -0.32 | -0.39 | -0.56 |
| EBITDA(a) | $-5,218 | $-5,016 | $-5,779 | $-5,382 | $-6,360 |